Pfizer Inc to Acquire Biohaven Pharmaceutical Holding Company Ltd - M&A Call Transcript
(technical difficulty)
Commentary and statements during the call regarding, amongst other topics, the proposed acquisition of Biohaven by Pfizer and Biohaven's and Pfizer's pipelines, in-line products and product candidates, which are subjects to risks and uncertainties, additional information regarding forward-looking statements is available under Risk Factors and forward-looking information and factors that may affect future results in our SEC filings on Forms 10-K and 10-Q and in the press release we issued this morning. Forward-looking statements on the call speak only as of the call's original date, and we undertake no obligation to update or revise any of the statements.
Joining us for the call today are Dave Denton, Pfizer's Chief Financial Officer; Angela Hwang, Group President, Pfizer Biopharmaceuticals Group; Aamir Malik, Chief Business and Innovation Officer; and Vlad Coric, Chief Executive Officer of Biohaven. Also joining us for the Q&A session will be Pfizer's Internal Medicine leadership team,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
